Treatment Options For Glioblastoma
Targeted Therapy

For some patients, targeted therapy might be beneficial. This treatment is focused on specific cancer cell abnormalities that make it possible for the cells to thrive and grow. These therapies help kill the cancer cells by attacking these abnormalities. A medication called bevacizumab is a common targeted treatment for glioblastoma because it can focus on the signals the cells of this cancer send to tell the body to create new blood vessels that will serve the tumor. With these blood vessels, the cancer cells are getting the nutrients and blood they require to live. By stopping these signals, bevacizumab essentially helps to starve the cells, allowing them to die. It is administered intravenously. The frequency and dosage depend on several factors, such as the patient’s cancer stage, general health, and the other treatments they are receiving.